Guminski, A., Foley, P., Grob, J.-J., Robert, C., Gutzmer, R. , Squittieri, N. and Kiecker, F. 2023. Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s181. DOI:https://doi.org/10.25251/skin.7.supp.181.